⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for geltamo

Every month we try and update this database with for geltamo cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell LymphomaNCT01014208
Lymphoma, Large...
OFATUMUMAB + DH...
RITUXIMAB + DHA...
18 Years - GlaxoSmithKline
Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse LymphomNCT00646750
Non-Hodgkin's L...
Ybritumomab Tiu...
18 Years - 70 YearsGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)NCT00644371
Non-Hodgkin Lym...
Ibritumomab Tiu...
18 Years - 65 YearsGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse LymphomNCT00646750
Non-Hodgkin's L...
Ybritumomab Tiu...
18 Years - 70 YearsGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: